Related by context. All words. (Click for frequent words.) 75 PXD# 74 ganetespib 74 HGS ETR1 74 obatoclax 74 PEG SN# 74 alvespimycin 74 INCB# [001] 73 ENMD # 73 HGS ETR2 73 HGS# 73 vascular disrupting agent 73 CA4P 73 AEG# 72 Symadex 72 fosbretabulin 72 sapacitabine 71 GRN#L 71 CCX# 71 APOPTONE 71 MGCD# [001] 71 oral prodrug 71 novel anticancer 71 PSN# [002] 71 OMP #M# 71 pertuzumab 70 antiangiogenic activity 70 CYT# potent vascular disrupting 70 CYC# 70 HuLuc# 70 ELACYT 70 RGB # 70 MGd 70 seliciclib 70 anti leukemic 70 vidofludimus 70 enzastaurin 70 huC# DM4 70 CYT# 70 Azixa 70 vascular disrupting agents 70 preclinically 70 #ME# 70 orally administered inhibitor 70 selective inhibition 70 AP# [003] 70 Aplidin R 70 MEK inhibitor 70 Aurora kinase 70 Cloretazine R 69 R#/MEM # 69 tyrosine kinase inhibitor 69 Seliciclib 69 Cloretazine R VNP#M 69 Preclinical studies 69 Bortezomib 69 ISIS # 69 SERMs 69 Sym# 69 lintuzumab 69 JAK1 69 Xanafide 69 targeting CD# 69 Omacetaxine 69 evaluating tivozanib 69 Sphingomab 69 EndoTAG TM -1 69 tubulin inhibitor 69 elotuzumab 69 ON #.Na 69 angiogenesis inhibitor 69 vascular disrupting 69 Cloretazine ® 69 imetelstat 69 ZYBRESTAT 69 MAGE A3 ASCI 69 talabostat 69 xenograft models 69 GRN# 69 MEK inhibitors 69 receptor tyrosine kinase inhibitor 69 mapatumumab 68 CORT # 68 HCD# [002] 68 MDV# 68 XL# [003] 68 cMET 68 Panzem R NCD 68 novel VDA molecule 68 CBLC# 68 HuMax CD# 68 IMC A# 68 mGluR2 NAM 68 AMD# [003] 68 Tyrima 68 atacicept 68 Angiolix 68 XmAb# 68 tanespimycin 68 immunomodulatory 68 pan HDAC inhibitor 68 Perifosine 68 potent anticancer 68 Apoptone 68 INGN 68 Panzem R 68 entinostat 68 AVN# [001] 68 eniluracil 68 metaglidasen 68 EOquin TM 68 Imprime PGG 68 CCR2 68 Phase Ib study 68 potent anti angiogenic 68 anti angiogenic 68 KRN# 68 proteasome inhibitor 68 PKC# 68 PSMA ADC 68 PDE4 inhibitor 68 TREANDA 68 Aplidin 68 XL# XL# 68 YONDELIS 68 microtubule targeting 68 ENMD 68 MOZOBIL 68 Factor VIIa 68 favorable pharmacokinetic profile 68 selective modulator 68 HDAC inhibition 68 Tarvacin TM 68 TRIOLEX 68 Traficet EN 68 EGFr 68 Azedra 68 Romidepsin 68 dacetuzumab 68 PS# [001] 67 investigational humanized monoclonal antibody 67 IL #E 67 protein kinase inhibitor 67 induce apoptosis 67 DXL# 67 celgosivir 67 small molecule defensin 67 antitumor activity 67 molecularly targeted 67 radiation sensitizer 67 SAR# [004] 67 decitabine 67 CR# vcMMAE 67 anticancer agent 67 NGX# 67 Thiarabine 67 deforolimus 67 IAP inhibitors 67 PRT# 67 elesclomol 67 forodesine 67 HSP# inhibitor 67 IMC #B 67 Atiprimod 67 Virulizin R 67 secretory phospholipase A2 sPLA2 67 CGEN # 67 Exherin TM 67 JAK inhibitors 67 OncoVEX GM CSF 67 PEG Interferon lambda 67 Ceflatonin 67 CD# monoclonal antibody 67 AQ4N 67 IAP inhibitor 67 MYDICAR ® 67 HCV protease 67 otelixizumab 67 selective kinase inhibitor 67 CD# CEA 67 Onconase 67 selective androgen receptor modulator 67 perifosine 67 antiangiogenic 67 BiTE antibodies 67 mertansine 67 JAK3 67 PNP inhibitor 67 HuMax EGFr 67 PF # [001] 67 Archexin 67 milatuzumab 67 HQK 67 elacytarabine 67 neratinib 67 Bendavia 67 EZN 67 Cloretazine 67 Annamycin 67 Nanobody 67 ARRY # 67 Voreloxin 67 tezampanel 67 phase Ib 67 nonclinical studies 67 ALN TTR 67 BCX# 67 Dapagliflozin 67 HDAC inhibitors 67 signal transduction inhibitor 67 MAP# 66 cilengitide 66 erlotinib Tarceva ® 66 Akt inhibitor 66 trodusquemine 66 GMX# 66 JAK2 inhibitor 66 Sapacitabine 66 R roscovitine 66 TELINTRA 66 #D#C# 66 BAY #-# 66 bortezomib Velcade 66 veltuzumab 66 Talactoferrin 66 TG# [003] 66 Epratuzumab 66 phase IIa clinical 66 HER3 66 GAP #B# 66 JAK inhibitor 66 ATL/TV# 66 Talabostat 66 Panzem 66 FGFR 66 Tarvacin 66 riociguat 66 PD LID 66 orally bioavailable 66 anti amnesic 66 axitinib 66 XL# XL# XL# 66 Carfilzomib 66 OvaRex R 66 VEGF receptor 66 anti fibrotic 66 Hsp# Inhibitor 66 phase IIb clinical 66 seliciclib CYC# 66 PLX# 66 Enzastaurin 66 MLN# 66 FLT3 66 antiproliferative effects 66 pomalidomide 66 amrubicin 66 immunomodulator 66 Phase Ib II 66 Hsp# inhibitors 66 LY# [003] 66 rNAPc2 66 PI3K inhibitor 66 voreloxin 66 CCR9 66 Alocrest 66 Aurora Kinase 66 liposomal formulation 66 multi kinase inhibitor 66 Zybrestat 66 EGFR HER2 66 Aflibercept 66 iSONEP 66 huN# DM1 66 Virulizin ® 66 preclinical efficacy 66 BiTE antibody 66 RG# [001] 65 demonstrated antitumor activity 65 trastuzumab Herceptin R 65 NXL# 65 PI3K/Akt pathway inhibitor 65 Phase #b/#a trial 65 Chemophase 65 Ocrelizumab 65 VEGF inhibitors 65 VEGFR2 65 histone deacetylase inhibitor 65 protein tyrosine phosphatase 1B 65 CTLA 4 65 mTOR inhibitors 65 GLYX 65 antitumor effects 65 EOquin 65 PLK1 SNALP 65 multitargeted 65 TRO# 65 anti proliferative 65 Amplimexon 65 potent antiproliferative 65 CEQ# 65 cannabinor 65 tafamidis 65 SYN# 65 NEUGENE 65 Thiovir 65 Tesetaxel 65 ASONEP 65 Trastuzumab 65 cancer immunotherapies 65 ATL# [001] 65 Tarceva TM 65 BAL# [001] 65 TBC# 65 anti CD3 65 BNC# 65 tesmilifene 65 PCK# 65 5 HT6 receptor 65 immunostimulatory 65 potent antitumor activity 65 daclizumab 65 Bezielle 65 EGS# 65 CDK inhibitor 65 Panzem NCD 65 epigenetic therapies 65 isoform selective 65 TOCOSOL Paclitaxel 65 alagebrium 65 humanized anti 65 HDAC inhibitor 65 sorafenib Nexavar 65 kinase inhibitor 65 oncolytic virus 65 volociximab 65 antitumor 65 Trofex 65 TELCYTA 65 Hsp# inhibitor 65 Blinatumomab 65 thalidomide Thalomid 65 histone deacetylase HDAC inhibitor 65 generation Hsp# inhibitor 65 Phase Ib clinical 65 Curaxin 65 Golimumab 65 GFT# 65 DOS# 65 Hedgehog pathway 65 LPA1 receptor 65 bortezomib Velcade ® 65 alkylating agent 65 vorinostat 65 chemotherapeutic drug 65 Squalamine 65 romidepsin 65 GW# [003] 65 ixabepilone 65 preclinical studies 65 ELND# 65 anti EGFR antibody 65 Phase Ib 65 HDAC Inhibitor 65 RAV# 65 CD# antibody [001] 65 mGluR5 NAM 65 immune modulatory 65 novel topoisomerase 65 ALK inhibitor 65 Randomized Phase 65 Bicifadine 65 varespladib 65 Kinase Inhibitor 65 PI3K/mTOR 65 BRIM2 65 cediranib 65 EndoTAGTM 1 65 iroxanadine 65 sodium glucose cotransporter 65 BRAF inhibitor 65 AKT inhibitor 65 Amrubicin 65 BIBW 65 antidiabetic 65 investigational monoclonal antibody 65 GRNCM1 64 HGS ETR1 mapatumumab 64 CLORETAZINE TM VNP#M 64 TAFA# 64 anticancer activity 64 anticancer compound 64 neuroprotectant 64 eltrombopag 64 potent inhibition 64 highly selective inhibitor 64 anti VEGF 64 XL# inhibits 64 BZL# 64 Indibulin 64 ZYBRESTAT fosbretabulin 64 VNP#M 64 cytoprotective 64 hematological cancers 64 delafloxacin 64 oxidative stress inducer 64 OHR/AVR# 64 pharmacodynamic PD 64 chemopreventive agent 64 Hsp# inhibition 64 gemcitabine Gemzar ® 64 CXB# 64 Triolex 64 Alzhemed TM 64 Curaxin CBLC# 64 T#I [002] 64 Pralatrexate 64 CUDC 64 KNS # 64 tesetaxel 64 glucagon receptor 64 alpha#beta# integrin 64 Phenoptin 64 PROSTVAC VF 64 Guanilib 64 bevacizumab Avastin ® 64 HDACi 64 Vitaxin 64 CCR9 antagonist 64 talactoferrin 64 peripherally acting 64 adecatumumab 64 EGFR inhibitors 64 FOLOTYN ® 64 rhIL 7 64 OncoVEX 64 galiximab 64 sorafenib Nexavar ® 64 Troxatyl 64 systemically administered 64 Xelox 64 p# inhibitor 64 Ceflatonin R 64 Lenocta 64 Prestara 64 pegylated liposomal doxorubicin 64 EGFR TKIs 64 paclitaxel Taxol 64 IGF 1R 64 TLK# 64 idarubicin 64 DermaVir Patch 64 Pimavanserin 64 MGCD# [002] 64 Tß4 64 Pertuzumab 64 CRLX# 64 IMA# 64 nab paclitaxel 64 antithrombotic 64 Tanespimycin 64 RhuDex ® 64 Targretin 64 insulin sensitizing 64 Vidofludimus 64 Fulvestrant 64 tyrosine kinase inhibitors 64 hematological malignancies 64 Valortim ® 64 #beta HSD1 64 carfilzomib 64 antiapoptotic 64 viral kinetics 64 AAG geldanamycin analog 64 neuroprotective properties 64 Aliskiren 64 estramustine 64 CoFactor 64 tumor vascular disrupting 64 XYOTAX TM 64 S/GSK# 64 TRAIL receptor antibodies 64 antibody MT# 64 proteasome inhibitors 64 Mipomersen 64 HuMax CD4 64 MT# MEDI 64 Dasatinib 64 histone deacetylase inhibitors 64 Zolinza 64 Phase #b/#a 64 TriRima 64 Eg5 64 Phase 1b 64 small molecule tyrosine 64 Trofex TM 64 Bafetinib 64 oral FTY# 64 Capesaris 64 AZD# 64 panobinostat 64 Janus kinase 64 induces apoptosis 64 HCV protease inhibitor 64 Antiangiogenic 64 Posiphen 64 PEGPH# 64 Amigal 64 RDEA# 64 vivo efficacy 64 Ophena TM 64 orally dosed 64 EP #R 64 pediatric acute lymphoblastic 64 ALN PCS 64 ularitide 64 telomerase inhibitor drug 64 Hedgehog pathway inhibitor 64 Phase 2b Clinical Trial 64 sunitinib Sutent ® 64 erythropoietic 64 docetaxel Taxotere ® 64 Phase 1a clinical 64 R sorafenib tablets 64 teriflunomide 64 ErbB 64 zanolimumab 64 depsipeptide 64 AEGR 64 Elotuzumab 64 relapsed multiple myeloma 64 SIRT1 activators 64 ANAVEX #-# [001] 64 Antitumor Activity 63 BiTE 63 TACI Ig 63 oral JAK1 63 ARIKACE ™ 63 Pathway Inhibitor 63 IMGN# 63 antisense inhibition 63 LY# [002] 63 samalizumab 63 INT# [002] 63 GSK# [001] 63 BCR ABL 63 Neulasta ® 63 preclinical 63 ALN TTR# 63 imatinib Gleevec ® 63 nucleoside analog 63 receptor inhibitor 63 Triapine R 63 PKCi 63 epothilone 63 Azedra TM 63 therapeutic monoclonal antibody 63 GVAX ® 63 gefitinib Iressa 63 thrombin receptor 63 muscarinic 63 generation nucleoside analog 63 fluoropyrimidine 63 apoptosis inducer 63 glufosfamide 63 docetaxel Taxotere R 63 ZD# [001] 63 pro angiogenic 63 pharmacodynamic properties 63 compound AEZS 63 PDX pralatrexate 63 Vidaza ® 63 pharmacodynamic 63 oncolytic 63 TRAIL induced apoptosis 63 VAPRISOL 63 TNFα 63 ISTODAX 63 XL# anticancer compounds 63 uric acid lowering 63 MAXY G# 63 LymphoStat B 63 generation purine nucleoside 63 preclinical models 63 Gemzar ® 63 PROSTVAC TM 63 Cethrin 63 TTR gene 63 Allovectin 7 R 63 Azacitidine 63 Synavive 63 aurora kinase 63 non nucleoside inhibitor 63 adipiplon 63 Genz # 63 belinostat 63 Fx #A 63 pharmacodynamic markers 63 NKTR 63 JAK2 inhibitors 63 Phase #b/#a clinical 63 gemcitabine Gemzar 63 ProLindac 63 velafermin 63 anti mitotic 63 ALN VSP 63 bardoxolone 63 ImmunoVEX HSV2 63 potent inhibitor 63 TKM ApoB 63 oral picoplatin 63 HER2 positive metastatic breast 63 lumiliximab 63 Epidermal Growth Factor Receptor 63 leukemia AML 63 selectively inhibit 63 brostallicin 63 T#I mutant 63 Omacetaxine mepesuccinate 63 plasma kallikrein inhibitor 63 LEP ETU 63 IgG1 antibody 63 polymerase inhibitor 63 Presents Preclinical Data 63 CIMZIA TM 63 Myocet 63 antisense inhibitors 63 pharmacokinetic PK study 63 Gleevec resistant 63 crizotinib PF # 63 mTOR inhibition 63 IMP# 63 CRx 63 c MYC 63 GLP toxicology studies 63 DAVANAT 63 vitro studies 63 potent cytotoxic 63 chemokine receptor 63 Phase 1b trial 63 JVRS 63 LE DT 63 selectively inhibits 63 antiangiogenesis 63 demethylating agents 63 pharmacodynamic effects 63 REOLYSIN ® 63 alpha antagonist 63 Phase #/#a trial 63 Androxal TM 63 NP2 Enkephalin 63 polymerase inhibitors 63 MT#/MEDI-# 63 Daclizumab 63 gastrin 63 darinaparsin 63 Deforolimus 63 Dacogen injection 63 selective antagonist 63 Zalypsis 63 Vilazodone 63 brivaracetam 63 ZYBRESTAT TM 63 PEGylated Fab fragment 63 HspE7 63 MET amplification 63 NS#/#A protease 63 novel immunomodulatory 63 omacetaxine 63 pro apoptotic 63 CCR5 mAb 63 HCV polymerase inhibitors 63 Lacosamide 63 Elesclomol 63 valopicitabine 63 Darinaparsin 63 immune modulating 63 anticancer therapies 63 trastuzumab DM1 T DM1 63 antibody MAb 63 sunitinib malate 63 Anavex #-# 63 Exelixis XL# 63 AeroLEF TM 63 telomerase therapeutic 63 SRT# [003] 63 ANG# 63 Personalized Immunotherapy 63 YONDELIS R 63 somatostatin analogue 63 bafetinib 63 Stedivaze 63 Cethromycin 63 RhuDex 63 AVE# 63 bortezomib 63 GV# [001] 63 PRX # 63 ApoB SNALP 63 2 methoxyestradiol 63 heavily pretreated 63 sitaxsentan 63 FOLFOX6 chemotherapy regimen 63 IRX 2 63 Proxinium TM 63 P#X# 63 immunomodulating 63 selective serotonin 2C receptor 63 CTAP# Capsules 63 dasatinib Sprycel 63 Neuradiab 63 Phase 2a trial 63 effector function 63 Preclinical Study 63 antiangiogenic agent 63 antitumor effect 63 bendamustine 63 DACH platinum 62 nicotinic alpha 7 62 visilizumab 62 cetuximab Erbitux 62 TRAIL R2 62 Exelixis compounds 62 Bavituximab 62 Tamibarotene 62 registrational trial 62 generation antisense inhibitor 62 Serdaxin 62 Temsirolimus 62 Granulocyte Colony Stimulating Factor 62 palifosfamide 62 IDX# 62 taxane resistant 62 TLE3 62 Phase 1b clinical trials 62 fibrotic disease 62 leading oral taxane 62 ALS #-# 62 small molecule thrombopoietin 62 Epothilones 62 masitinib 62 triphendiol 62 PI3K Akt 62 rindopepimut 62 antitumor efficacy 62 ALB # 62 Smac mimetic 62 lenalidomide dexamethasone 62 adecatumumab MT# 62 taxane 62 myelofibrosis polycythemia vera 62 Nanobody ® 62 GSK3B 62 ofatumumab 62 AMPK activators 62 ERK1 2 62 GALNS 62 anti CTLA 62 THR beta agonist 62 relapsed acute myelogenous 62 Telintra 62 MCSP respectively 62 PhG alpha 1 62 alpha folate receptor 62 novel peptide 62 Litx 62 ACZ# 62 histone deacetylase HDAC 62 vosaroxin 62 Maribavir 62 davunetide intranasal AL 62 Bevacizumab 62 TLR7 62 menadione 62 pharmacokinetic PK 62 torezolid phosphate 62 anti angiogenic drugs 62 Cannabinor 62 GM CSF 62 candidate CRLX# 62 cancer mCRC 62 docetaxel chemotherapy 62 olaparib 62 nucleoside analogs 62 xenograft tumor models 62 PEGylated 62 LBH# 62 Glufosfamide 62 FK# 62 E#F# 62 IL# PE#QQR 62 PEG PAL 62 Kevetrin 62 refractory chronic lymphocytic 62 Pazopanib 62 Teriflunomide 62 UPLYSO 62 IMiDs R 62 CD3 monoclonal antibody 62 Allovectin 7 62 Tezampanel 62 EGFR pathway 62 HMG CoA reductase inhibitors 62 paclitaxel Taxol ® 62 targeted radiotherapeutic 62 UVIDEM 62 oral Xeloda 62 immunomodulation 62 acadesine 62 SCH # 62 Pivotal Phase 62 nucleotide analog 62 Liposomal 62 Cotara 62 geldanamycin 62 EGFR TKI 62 CG# [003] 62 FOLOTYN 62 Irinotecan 62 hypoxia inducible factor 62 immuno modulatory 62 initiate Phase 1b 62 triterpenoids 62 ospemifene 62 ADP receptor antagonist 62 phase IIa 62 Insegia 62 imatinib therapy 62 MPS IVA 62 reslizumab 62 R#/MEM 62 JAK2 62 Solazed TM 62 ICA # 62 phase IIb trial 62 regorafenib 62 GRNVAC1 62 radezolid 62 Kahalalide F 62 cetuximab Erbitux ® 62 azacytidine 62 Varespladib 62 chemopreventive 62 novel tubulin binding 62 agonistic human 62 MERLIN TIMI 62 maximally tolerated dose 62 Tyrosine Kinase Inhibitor 62 Anticalin ® 62 Darusentan 62 HDAC 62 LT NS# 62 lesinurad 62 MAXY alpha 62 ataluren 62 virus HCV protease inhibitor 62 Revimmune 62 mitotic kinesins 62 sorafenib tablets 62 PRECISE trial 62 Degarelix 62 Valortim 62 VELCADE melphalan 62 ZOLINZA 62 BMS# 62 CCR5 antagonist 62 goserelin 62 Smac mimetics 62 Presents Preclinical 62 K ras mutations 62 Nexavar ® 62 Preclinical studies suggest 62 humanized antibody 62 small molecule activator 62 HIF PHI 62 nucleoside 62 multikinase inhibitor 62 Angiocept 62 Anticalin R 62 Quinamed 62 nanoviricides 62 tumorigenic 62 rxRNA 62 farletuzumab 62 solithromycin 62 Solazed 62 tumor necrosis 62 TH# [003] 62 mGluR5 negative 62 Azedra ™ 62 Xcytrin 62 HERmark 62 JAK Inhibitor 62 vinca alkaloid 62 Rigel R# 62 indibulin 62 PrevOnco 62 OncoVex 62 VA# [002] 62 EpCAM 62 Lu AA# 62 Aptivus ® 62 bexarotene 62 ongoing Phase 1b 62 TYKERB 62 OMP #R# 62 Catena ® 62 nalbuphine ER 62 Erlotinib 62 SCCHN 62 rFIXFc 62 NOX E# 62 Pentraxin 2 62 immunoregulatory 62 cisplatin resistant 62 SNT MC# 62 MetMAb 62 inhibiting tumor 62 induced tumor regression 62 zileuton 62 Phase 2a 62 teplizumab 62 tumor xenograft models 62 IFN α 62 DB# [003] 62 Novel Oral 62 telomerase inhibition 62 Protein Kinase C 62 androgen independent 62 Palifosfamide 62 ceftaroline 62 bosutinib 62 Tumor Necrosis Factor 62 HDAC EGFR 62 cytotoxic 62 mTOR mammalian target 62 PI3 kinase 62 immune stimulatory 62 OPAXIO 62 TRAIL receptor 62 ONCONASE R 62 JAK#/JAK# 62 Belinostat 62 EGFR tyrosine kinase inhibitors 62 Everolimus 62 PDE# inhibitors 62 mitogen activated ERK kinase 62 multicenter Phase II 62 flavopiridol 62 Vandetanib 62 A3 adenosine receptor 62 DDP# 62 Plicera 62 bortezomib Velcade R 62 ThermoDox ® clinical 62 NS5A 62 LymphoStat B TM 62 TRX1 62 pharmacokinetic interactions 62 SPRYCEL ® 62 XP# XP# 62 Iloperidone 62 pralatrexate 62 imatinib Gleevec 62 rhIGFBP 3 62 teduglutide 62 G#DT 62 drug conjugate 62 GSK # 62 RNAi therapeutic targeting 62 rALLy trial 62 MVA BN R 62 ONCONASE 62 ATL# [002] 61 HCV protease inhibitors 61 DFMO 61 kinase inhibitors 61 PDGFR 61 bone metastasis 61 Rasagiline 61 Arimoclomol 61 apoptosis proteins 61 Neuvenge 61 Tavocept 61 PROCHYMAL 61 poly ADP ribose polymerase 61 Wnt signaling pathway 61 XL# XL# XL# XL# 61 thrombopoietin 61 Pivotal Phase III 61 TRISENOX 61 pDCs 61 eculizumab 61 Desmoteplase 61 COX2 61 gamma secretase inhibitor 61 ALKS 61 NEUMUNE 61 BRIM3 61 Tasimelteon 61 NeuroVax TM